What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)
These two ratios provide an indication of how successful a company is at generating profits using shareholders' funds and debt, and they have a strong influence on dividend payments...
Posts Tagged ‘GlaxoSmithKline plc (GSK)’
Why Loss of Viagra Patent Will Not Harm Pfizer Inc. (PFE)
Viagra changed the way below-the-belt jokes were told, and certainly, it empowered a lot of men in ways they couldn't have imagined. Without a doubt, Pfizer Inc.
3 Things to Loathe About GlaxoSmithKline plc (ADR) (GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s long-run total return for shareholders (capital appreciation and dividends over the past 10 years) has lagged behind that of the average...
Is It Still Safe to Buy GlaxoSmithKline plc (ADR) (GSK)?
LONDON -- I'm always searching for shares that can help ordinary investors like you make money from the stock market.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): Will These Pharma Stocks Maintain Their Yields?
High dividend pharmaceutical stocks have been extremely popular in recent years.
Amarin Corporation plc (ADR) (AMRN): Something Fishy? Or Business as Usual?
Mark your calendars Amarin Corporation plc (ADR) (NASDAQ:AMRN) investors.
Why I Think GlaxoSmithKline plc (GSK) Is So Much More Than Just an Income Stock
Indeed, the shares currently yield an impressive 4.4% despite rising by more than 30% in the last three years alone.
Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK): The Top 3 Medical Uses of Botox
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
Three Views for Sarepta Therapeutics Inc (SRPT) on Prosensa’s IPO
Sarepta Therapeutics Inc (NASDAQ:SRPT) won't be the only stock choice for a biotech focusing on Duchenne muscular dystrophy, or DMD, much longer. Its one potential challenger...
AstraZeneca plc (ADR) (AZN): Is This Purchase a Game-Changer?
London-based pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) recently announced that it had agreed to purchase U.S.-based lung-drug manufacturer Pearl Therapeutics for at...
Why MannKind Corporation (MNKD) Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company MannKind Corporation...
GlaxoSmithKline plc (ADR) (GSK): Does Restless Legs Syndrome Really Shorten Life Span?
It may surprise you, but restless legs syndrome (RLS) affects 7% to 10% of the U.S. population, with varying degrees of severity.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): A Big Pharma Company With a Juicy Dividend Yield and Low Valuation
Recently, AstraZeneca plc (ADR) (NYSE:AZN) announced that it has agreed to acquire Pearl Therapeutics, the respiratory drug manufacturer, in a transaction worth around $1.15 billion...
AstraZeneca plc (ADR) (AZN), Novartis AG (ADR) (NVS): 5 Biotech Giants with Lucrative Dividend Yields
Investing in biotech stocks is relatively risky amid the volatility of the market. There are many factors that can greatly affect share trends and price performance.
Regeneron Pharmaceuticals Inc. (REGN), GlaxoSmithKline plc (GSK): The First Real Cure in the $25 billion Asthma Market?
Everyone has had a friend at school who was asthmatic. Life is not easy for the chronic asthmatic.
What to Know About GlaxoSmithKline plc (ADR) (GSK)
This money coming in is cash flow, and looking at a company's cash flow gives us -- as current or potential shareholders -- a sense of how well that company is doing at selling...
AstraZeneca plc (ADR) (AZN)’s Acquisition of Omthera Pharmaceuticals Inc (OMTH) Is a Desperate Act
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Sarissa’s Stake in Vivus, Inc. (VVUS) Points to Renewed Interest in the Company
Noted hedge fund Sarissa Capital Management recently disclosed a stake of nearly 2% in promising biotechnology firm VIVUS, Inc. (NASDAQ:VVUS) .
Pfizer Inc. (PFE)’s Big Chance
When we think of big pharma companies, the company we think about constantly is Pfizer Inc.
How AstraZeneca plc (ADR) (AZN) Measures Up as a GARP Investment
LONDON -- A popular way to dig out reasonably priced stocks with robust growth potential is through the "Growth at a Reasonable Price," or GARP, strategy.
Vodafone Group Plc (ADR) (VOD), Tate & Lyle PLC (TATE): Neil Woodford’s Latest Buys and Sells
Through his Invesco Perpetual Income and High Income funds, Woodford looks after more than 20 billion pounds of client money.
Merck & Co., Inc. (MRK), Celgene Corporation (CELG): 3 FDA Stories You Missed Last Week
Editor's Note: The initial article refers to Abraxane's prostate cancer trials. That is incorrect, Abraxane has priority review for pancreatic cancer.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK): Three FDA Stories You Missed Last Week
The Food and Drug Administration stays busy with approvals, recommendations, and reviews.
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY): Pharma Big Wigs Warm Up to Africa’s $40 Billion Opportunity
For a long time, Africa’s traditional enemy with regard to diseases have been communicable diseases like HIV and Malaria. Now, however, this trend is changing.
Does Novartis AG (ADR) (NVS) Pass Buffett’s Test?
We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more.
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): 5 Costliest Microbes in Financial History
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
G4S plc (GFS), National Grid plc (ADR) (NGG): Five Shares to Avoid Market Madness
LONDON -- I've trawled the market to find the shares that have previously been least affected by big market rises or falls.
Compass Group plc (CPG), ARM Holdings plc (ADR) (ARMH), GlaxoSmithKline plc (ADR) (GSK): 3 Shares to Gain From Powerful Global Trends
LONDON -- The economic crisis has forced governments worldwide to consider how they can deliver services more efficiently. Frequently, they are turning to the private sector.
GlaxoSmithKline plc (GSK): The Perfect Tonic for Troubled Markets
LONDON -- If you can keep your head while everyone around is losing theirs, you probably hold shares in GlaxoSmithKline plc (LON:GSK).
General Electric Company (GE) Vs Two Alternatives
General Electric Company (NYSE:GE) steadily pays out dividends to its shareholders. The payout amount has been increasing year over year for three years in a row.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) Are NOT The Newest Obesity Drug Player
VIVUS, Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals, Inc.
Three Things About to Move Pfizer Inc. (PFE) Stock
Large, multinational companies have an unprecedented number of things pulling and pushing on their share price.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): Tuesday’s Top Upgrades & Downgrades
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
The City News: InterContinental Hotels Group PLC (IHG), Barclays PLC (BARC), GlaxoSmithKline plc (GSK) & More
Editor's Note: Related tickers: JPMorgan Chase & Co.
Vodafone Group Plc (ADR) (VOD), GlaxoSmithKline plc (ADR) (GSK), Anheuser-Busch InBev NV (ADR) (BUD): German, French Indices Vulnerable at Elevated Levels
The Eurozone debt problems have held as a central focus of the financial markets since 2010.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY), AbbVie Inc (ABBV): The 5 Highest-Paying Dividend Stocks in Big Pharma
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Three Reasons to Love GlaxoSmithKline plc (GSK)
LONDON -- It's been a long tough slog for GlaxoSmithKline plc (LON:GSK) shares, but things are looking up.
GlaxoSmithKline plc (ADR) (GSK), ConocoPhillips (COP): Buffett’s Favorite Yielders
TheStreet.com recently ran an article outlining five companies that Warren Buffett holds in his portfolio that yield 3% or better.
GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc (THRX): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK): The U.S.’s Deadliest Diseases
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Vodafone Group Plc (ADR) (VOD), Verizon Communications Inc. (VZ), GlaxoSmithKline plc (ADR) (GSK): How’s The Beginners’ Portfolio Doing?
LONDON -- The Beginners' Portfolio made its first buy, of Vodafone Group Plc (ADR) (NASDAQ:VOD) shares, on May 18, 2012 -- and the first anniversary of the fateful day will be...
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Is Gilead Sciences, Inc. (GILD) Still A Buy?
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership?
Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies.
3 FTSE 100 Shares Hitting New Highs: GlaxoSmithKline plc (GSK), BT Group plc (BT.A), British American Tobacco plc (BATS)
LONDON -- The FTSE 100 set a five-and-a-half-year record of 6,638 points last Friday, and though the index is down from that today at 6,617, it still looks like hanging on to...
